(1α,1'S,4β)-Lanabecestat (Synonyms: (1α,1'S,4β)-AZD3293; (1α,1'S,4β)-LY3314814) |
| Katalog-Nr.GC38489 |
(1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) ein weniger aktives Enantiomer von Lanabecestat.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1384082-96-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) is a Beta site APP Cleaving Enzymel (BACE1) inhibitor extracted from patent WO2012087237A1, compound 20a, has IC50s of 2.2 nM (TR-FRET assay) and 0.28 nM (sAPPp release assay), respectively[1].
[1]. Gabor Csjernyik, et al. Compounds and their use as bace inhibitors. WO2012087237A1.
Average Rating: 5 (Based on Reviews and 15 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *